Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
Diagnosis of vascular dementia is hampered by the lack of biochemical markers for this disease. Here, the authors show that vascular dementia is associated with increased lipocalin-2 in cerebrospinal fluid, compared to controls and patients with other forms of dementia.
Guardado en:
Autores principales: | Franc Llorens, Peter Hermann, Anna Villar-Piqué, Daniela Diaz-Lucena, Katarina Nägga, Oskar Hansson, Isabel Santana, Matthias Schmitz, Christian Schmidt, Daniela Varges, Stefan Goebel, Julien Dumurgier, Henrik Zetterberg, Kaj Blennow, Claire Paquet, Inês Baldeiras, Isidro Ferrer, Inga Zerr |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb0e9a75338a4a03b999da9efd91d3b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Lovisa Tobieson, et al.
Publicado: (2021) -
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
por: Mikko Hölttä, et al.
Publicado: (2012) -
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2021) -
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2020) -
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study
por: Kenji Hashimoto, et al.
Publicado: (2017)